[Association between vaccination and the risk of immunoglobulin A vasculitis in children].
- 15 November 2023
- journal article
- abstracts
- Vol. 25 (11) , 1137-1142
Abstract
To study the effect of vaccination on the short-term risk of immunoglobulin A vasculitis (IgAV) in children. A retrospective analysis was conducted on the general data and the vaccination history within one year prior to onset in children with IgAV hospitalized in the Children's Hospital Affiliated to Zhengzhou University from November 2021 to January 2023. Vaccine exposure rates in the risk period (3 months prior to IgAV onset) and the control period were compared by autocontrol-case crossover analysis, and the odds ratio and 95% confidence interval (95%CI) were calculated. A sensitivity analysis for the one-month and two-month risk periods was conducted. A total of 193 children with IgAV were included, with a median age of 7.0 years. Among the 193 children, 36 (18.7%) received at least one dose of the vaccine within 1 year prior to IgAV onset, and 14 (7.3%) received at least one dose of the vaccine during the 3-month risk period. Compared to the unvaccinated IgAV group, the vaccinated IgAV group had a significantly younger age of onset (P0.05). The odds ratio for developing IgAV after receiving any type of vaccine within 3 months prior to IgAV onset was 2.08 (95%CI: 0.82-5.27, P>0.05). Further sensitivity analysis for the 1-month and 2-month risk periods demonstrated that the odds ratios for developing IgAV after receiving any type of vaccine were 2.74 (95%CI: 0.72-10.48, P>0.05) and 2.72 (95%CI: 0.95-7.77, P>0.05), respectively. Vaccination dose not increase the risk of IgAV, nor does it exacerbate clinical symptoms in children with IgAV.Keywords
This publication has 24 references indexed in Scilit:
- Vaccination and Risk of Childhood IgA VasculitisPediatrics, 2018
- Protecting the Community Through Child VaccinationClinical Infectious Diseases, 2018
- Vaccine-associated hypersensitivityJournal of Allergy and Clinical Immunology, 2018
- Henoch-Schönlein Purpura and Influenza VaccineThe Journal of Allergy and Clinical Immunology: In Practice, 2017
- Henoch-Schönlein purpura and drug and vaccine use in childhood: a case-control studyItalian Journal of Pediatrics, 2016
- Henoch-Schönlein purpura after hepatitis A vaccinationAnnals of Allergy, Asthma & Immunology, 2011
- Measles vaccine adverse events reported in the mass vaccination campaign of Sichuan province, China from 2007 to 2008Vaccine, 2011
- Henoch-Schönlein purpura following influenza vaccinations during the pandemic of influenza A (H1N1)Pediatric Nephrology, 2010
- Henoch-Schonlein purpura and meningococcal B vaccinationArchives of Disease in Childhood, 2009
- Vaccinations and the Risk of Relapse in Multiple SclerosisNew England Journal of Medicine, 2001